Merck KGAA's Hostile Bid Catalyzes Bayer-Schering Combo

In March 2006, Bayer AG's €16.3 billion ($19.6 billion) cash offer for Schering trumped compatriot Merck KGAA's unsolicited €14.6 billion takeover bid for the specialist pharma marketer. The offers to acquire Schering put a spotlight on Europe's mid-sized players, most of which are either on the acquisition trail or putting up For Sale signs in front of corporate headquarters.

Schering AG CEO Hubertus Erlen, PhD, has long espoused the value of franchise building and specialist marketing. (See "Schering: Addressing the Specialist Challenge," IN VIVO, November 2004 Also see "Schering: Addressing the Specialist Challenge" - In Vivo, 1 November, 2004..) Now he can finally put a number on that value: about $20 billion.

In March 2006, Bayer AG 's €16.3 billion ($19.6 billion) cash offer for Schering trumped compatriot Merck KGAA ...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Business Strategy

More from In Vivo